184 related articles for article (PubMed ID: 28079986)
1. Establishment of an in vitro three-dimensional model for cartilage damage in rheumatoid arthritis.
Peck Y; Leom LT; Low PFP; Wang DA
J Tissue Eng Regen Med; 2018 Jan; 12(1):e237-e249. PubMed ID: 28079986
[TBL] [Abstract][Full Text] [Related]
2. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts.
Neidhart M; Gay RE; Gay S
Arthritis Rheum; 2000 Aug; 43(8):1719-28. PubMed ID: 10943861
[TBL] [Abstract][Full Text] [Related]
3. Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study.
Andreas K; Lübke C; Häupl T; Dehne T; Morawietz L; Ringe J; Kaps C; Sittinger M
Arthritis Res Ther; 2008; 10(1):R9. PubMed ID: 18205922
[TBL] [Abstract][Full Text] [Related]
4. Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation.
Xue M; McKelvey K; Shen K; Minhas N; March L; Park SY; Jackson CJ
Rheumatology (Oxford); 2014 Dec; 53(12):2270-9. PubMed ID: 24982240
[TBL] [Abstract][Full Text] [Related]
5. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
6. A three-dimensionally engineered biomimetic cartilaginous tissue model for osteoarthritic drug evaluation.
Peck Y; Ng LY; Goh JY; Gao C; Wang DA
Mol Pharm; 2014 Jul; 11(7):1997-2008. PubMed ID: 24579704
[TBL] [Abstract][Full Text] [Related]
7. 1, 25-dihydroxy-vitamin D3 with tumor necrosis factor-alpha protects against rheumatoid arthritis by promoting p53 acetylation-mediated apoptosis via Sirt1 in synoviocytes.
Gu X; Gu B; Lv X; Yu Z; Wang R; Zhou X; Qiao W; Mao Z; Zuo G; Li Q; Miao D; Jin J
Cell Death Dis; 2016 Oct; 7(10):e2423. PubMed ID: 27763638
[TBL] [Abstract][Full Text] [Related]
8. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
9. Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis.
Korb-Pap A; Stratis A; Mühlenberg K; Niederreiter B; Hayer S; Echtermeyer F; Stange R; Zwerina J; Pap T; Pavenstädt H; Schett G; Smolen JS; Redlich K
Ann Rheum Dis; 2012 Jun; 71(6):1004-11. PubMed ID: 22258493
[TBL] [Abstract][Full Text] [Related]
10. GDF-5 is suppressed by IL-1beta and enhances TGF-beta3-mediated chondrogenic differentiation in human rheumatoid fibroblast-like synoviocytes.
Liu FL; Lin LH; Sytwu HK; Chang DM
Exp Mol Pathol; 2010 Feb; 88(1):163-70. PubMed ID: 19818765
[TBL] [Abstract][Full Text] [Related]
11. Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response.
Furuzawa-Carballeda J; Macip-Rodríguez PM; Cabral AR
Clin Exp Rheumatol; 2008; 26(4):554-60. PubMed ID: 18799084
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis.
Barksby HE; Milner JM; Patterson AM; Peake NJ; Hui W; Robson T; Lakey R; Middleton J; Cawston TE; Richards CD; Rowan AD
Arthritis Rheum; 2006 Oct; 54(10):3244-53. PubMed ID: 17009259
[TBL] [Abstract][Full Text] [Related]
13. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast-like synoviocyte-chondrocyte interaction in cartilage degradation.
Steenvoorden MM; Bank RA; Ronday HK; Toes RE; Huizinga TW; DeGroot J
Clin Exp Rheumatol; 2007; 25(2):239-45. PubMed ID: 17543148
[TBL] [Abstract][Full Text] [Related]
15. Parthenolide inhibits pro-inflammatory cytokine production and exhibits protective effects on progression of collagen-induced arthritis in a rat model.
Liu Q; Zhao J; Tan R; Zhou H; Lin Z; Zheng M; Romas E; Xu J; Sims NA
Scand J Rheumatol; 2015 May; 44(3):182-91. PubMed ID: 25439190
[TBL] [Abstract][Full Text] [Related]
16. Acid-Sensing Ion Channel-1a in Articular Chondrocytes and Synovial Fibroblasts: A Novel Therapeutic Target for Rheumatoid Arthritis.
Xu Y; Chen F
Front Immunol; 2020; 11():580936. PubMed ID: 33584647
[TBL] [Abstract][Full Text] [Related]
17. Growth characterization of neo porcine cartilage pellets and their use in an interactive culture model.
Lübke C; Ringe J; Krenn V; Fernahl G; Pelz S; Kreusch-Brinker R; Sittinger M; Paulitschke M
Osteoarthritis Cartilage; 2005 Jun; 13(6):478-87. PubMed ID: 15922182
[TBL] [Abstract][Full Text] [Related]
18. Modulation of fibroblast-mediated cartilage degradation by articular chondrocytes in rheumatoid arthritis.
Pap T; van der Laan WH; Aupperle KR; Gay RE; Verheijen JH; Firestein GS; Gay S; Neidhart M
Arthritis Rheum; 2000 Nov; 43(11):2531-6. PubMed ID: 11083277
[TBL] [Abstract][Full Text] [Related]
19. Comparison of different chondrocytes for use in tissue engineering of cartilage model structures.
Isogai N; Kusuhara H; Ikada Y; Ohtani H; Jacquet R; Hillyer J; Lowder E; Landis WJ
Tissue Eng; 2006 Apr; 12(4):691-703. PubMed ID: 16674284
[TBL] [Abstract][Full Text] [Related]
20. The loss of α2β1 integrin suppresses joint inflammation and cartilage destruction in mouse models of rheumatoid arthritis.
Peters MA; Wendholt D; Strietholt S; Frank S; Pundt N; Korb-Pap A; Joosten LA; van den Berg WB; Kollias G; Eckes B; Pap T
Arthritis Rheum; 2012 May; 64(5):1359-68. PubMed ID: 22083543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
